SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001213900-24-054003
Filing Date
2024-06-20
Accepted
2024-06-20 07:01:40
Documents
21
Period of Report
2024-06-20
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT ea0208142-8k_aldeyra.htm   iXBRL 8-K 23646
2 ALDEYRA THERAPEUTICS, INC. PRESS RELEASE DATED JUNE 20, 2024 ea020814201ex99-1_aldeyra.htm EX-99.1 28111
3 GRAPHIC ex99-1_001.jpg GRAPHIC 3779
4 GRAPHIC ex99-1_002.jpg GRAPHIC 479647
5 GRAPHIC ex99-1_003.jpg GRAPHIC 517838
6 GRAPHIC ex99-1_004.jpg GRAPHIC 534511
7 GRAPHIC ex99-1_005.jpg GRAPHIC 620865
8 GRAPHIC ex99-1_006.jpg GRAPHIC 632230
9 GRAPHIC ex99-1_007.jpg GRAPHIC 530777
  Complete submission text file 0001213900-24-054003.txt   4799407

Data Files

Seq Description Document Type Size
10 XBRL SCHEMA FILE aldx-20240620.xsd EX-101.SCH 3012
11 XBRL LABEL FILE aldx-20240620_lab.xml EX-101.LAB 34240
12 XBRL PRESENTATION FILE aldx-20240620_pre.xml EX-101.PRE 22357
24 EXTRACTED XBRL INSTANCE DOCUMENT ea0208142-8k_aldeyra_htm.xml XML 3688
Mailing Address 131 HARTWELL AVENUE SUITE 320 LEXINGTON MA 02421
Business Address 131 HARTWELL AVENUE SUITE 320 LEXINGTON MA 02421 781-761-4904
Aldeyra Therapeutics, Inc. (Filer) CIK: 0001341235 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36332 | Film No.: 241054030
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)